Aerie Pharmaceuticals reported $-30761000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Amarin AMRN:US $ 1.82M 7.74M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Coherus Biosciences CHRS:US $ -31.9M 8.61M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Flexion Therapeutics FLXN:US $ -23631000 7.27M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Horizon Pharma HZNP:US $ 439.93M 134.24M
Insmed INSM:US $ -91545000 6.9M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Novartis NOVN:VX SF 4837M 65M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Supernus Pharmaceuticals SUPN:US $ 38.61M 2.15M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
Valeant Pharmaceuticals VRX:CN $ 799M 67M
Zoetis ZTS:US $ 845M 7M
Zogenix ZGNX:US $ -51.9M 1.17M